Infection by bovine papillomavirus and prospects for vaccination.
Infection with bovine papillomavirus (BPV) results in the onset of benign proliferative lesions that usually regress spontaneously through a cell-mediated immune response. Occasionally, warts persist as benign tumours or progress to squamous-cell carcinomas. Vaccines that prevent or cure BPV infection provide a model for the formulation of vaccines against human papillomavirus.
Campo
M S
MS
Beatson Institute for Cancer Research, CRC Beatson Laboratories, Glasgow, UK.
D000818:Animals; D052688:Bovine papillomavirus 1 / Q000235:genetics / Q000276:immunology*; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D006801:Humans; D010212:Papilloma / Q000209:etiology / Q000517:prevention & control / Q000821:virology; D030361:Papillomavirus Infections / Q000235:genetics / Q000517:prevention & control*; D014412:Tumor Virus Infections / Q000235:genetics / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000821:virology; D014611:Vaccination